In addition to an increase in the number of confirmed cases in the Birmingham school cluster (Handsworth) to 64, Eton College has taken the decision to remain closed for an additional week beyond the half-term break after a student was diagnosed with A(H1N1).
http://news.bbc.co.uk/1/hi/uk/8072679.stm
The UK case total now stands at 203
http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1243467936876?p=1231252394302
A(H1N1) is also now spreading in the Philippines with 10 confirmed cases. These cases include a cluster of individuals who attended a wedding in Zambales last weekend.
http://www.philstar.com/Article.aspx?articleId=472370&publicationSubCategoryId=63
Worldwide, there have been 95 deaths and an estimated 13,450 cases.
GOOD NEWS:
The good news is that the development of an A(H1N1) vaccine is moving forward. Researchers at the NIBSC have successfully produced a hybrid virus (cross between a disease causing H1N1 strain and a tested lab strain) that will hopefully produce a protective immune reponse in vaccinees without causing disease. This is a crucial step in the production of a safe and effective vaccine.
http://news.bbc.co.uk/1/hi/health/8071758.stm
http://news.bbc.co.uk/1/hi/uk/8072679.stm
The UK case total now stands at 203
http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1243467936876?p=1231252394302
A(H1N1) is also now spreading in the Philippines with 10 confirmed cases. These cases include a cluster of individuals who attended a wedding in Zambales last weekend.
http://www.philstar.com/Article.aspx?articleId=472370&publicationSubCategoryId=63
Worldwide, there have been 95 deaths and an estimated 13,450 cases.
GOOD NEWS:
The good news is that the development of an A(H1N1) vaccine is moving forward. Researchers at the NIBSC have successfully produced a hybrid virus (cross between a disease causing H1N1 strain and a tested lab strain) that will hopefully produce a protective immune reponse in vaccinees without causing disease. This is a crucial step in the production of a safe and effective vaccine.
http://news.bbc.co.uk/1/hi/health/8071758.stm
No comments:
Post a Comment